[Oral therapy of interstitial cystitis].
Up to now there is no specific treatment targeting the ultimate cause of interstitial cystitis (IC), since its pathogenesis and etiology are still unknown. Most studies focussing on oral medication have not been randomized, double-blinded or placebo-controlled. Numerous case reports and intent-to-treat trials are lacking a systematic approach and do not meet evidence-based medicine criteria. Consequently there is as yet no standard oral therapy available for the treatment of IC. However, only a few oral substances have shown a potential to improve symptoms such as frequency and pain. The best results were obtained from monotherapeutic use of pentosanpolysulfate, amitriptylin and hydroxycin. The true benefit of these substances alone should be compared to analgesics and anticholinergics in the course of controlled clinical trials.
Sievert
K D
KD
Klinik und Poliklinik für Urologie, Westfälische Wilhelms-Universität Münster.
Edenfeld
K D
KD
Oberpenning
F
F
Piechota
H J
HJ
D000284:Administration, Oral; D000639:Amitriptyline / Q000008:administration & dosage; D000700:Analgesics / Q000008:administration & dosage; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D018856:Cystitis, Interstitial / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D006919:Hydroxyzine / Q000008:administration & dosage; D010426:Pentosan Sulfuric Polyester / Q000008:administration & dosage; D013256:Steroids; D016896:Treatment Outcome
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D013256:Steroids; D000639:Amitriptyline; D006919:Hydroxyzine; D010426:Pentosan Sulfuric Polyester